10 Apr 2017
(MENAFN) Egypt should enhance its collaboration in pharmaceutical sector with India, which has great advantages in terms of offering affordable and reliable medication.
Accordingly, Egypt is a huge market in which India sees growing export potentials as well as possibilities of investments, while it aims that the market will offer India the base to increase to other parts of the region.
Additionally, India formulation is backed by globally acceptable certification and updated by increasing R&D facilities.
India’s exports of pharmaceuticals in 2015/16 reached USD16.86bn, while Indian pharmaceutical industry with several thousand producers, export the largest share of generics to the world.
MENAFN1004201700450000ID1095382304
MENAFN1004201700450000ID1095382304
12 May 2025
Alsharifi: “Proud of our strategic partnership with the Royal Humanitarian Foundation”
04 May 2025
BBK offers exclusive Mortgage Loans for luxury villas and apartments on Reef Island
30 Apr 2025
BBK discloses its financial results for the first quarter ended 31st March 2025
25 Mar 2025
BBK’s General Assembly Approves 35% Cash Dividend Distribution to Shareholders
12 Mar 2025
Mr. Yaser Alsharifi completes Harvard Business School Presidents’ Program in Leadership
19 Feb 2025
Bank of Bahrain and Kuwait BSC announces the transfer of HSBC Middle East, Bahrain Retail Business to BBK.
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more